Effect of anti-tumor necrosis factor α treatment on radiographic progression in patient with ankylosing spondylitis: A systematic review and meta-analysis

Modern Rheumatology
He-Xiang ZongYu-Zhu Teng

Abstract

Efficacy of anti-tumor necrosis factor (anti-TNF)α treatment in patient with active ankylosing spondylitis (AS) had been proved by many clinical studies. Inflammation and new bone formation in spine were two pivotal aspects in AS. TNF α inhibitor could eliminate inflammation including clinical and laboratory inflammatory manifestation. Paradoxical results whether TNF α antagonist could delay radiographic progression in AS were often been reported simultaneously. To review the literature about the effect of TNF α inhibitor on radiographic progression and disease activity in patient with AS. We conducted a comprehensive search including Medline, EMBASE and the Cochrane Library from 1 January 2000 to 15 August 2017. Two reviewers independently supplemented with hand searching for the reference lists of inclusion. All trials focusing on radiographic progression or disease activity in patients with AS treated with anti-TNF α agents. Primary outcomes were modified Stokes AS Spinal Score (mSASSS), as well as Bath AS disease activity index (BASDAI) and Bath AS functional index (BASFI). Two reviewers independently selected studies and analyzed data. Methodological quality was assessed using the Newcastle-Ottawa scale (NOS). We pooled ef...Continue Reading

References

Aug 31, 2002·Endocrine Reviews·Ann CranneyUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Mar 31, 2004·Annals of the Rheumatic Diseases·M C W CreemersP L C M van Riel
Feb 5, 2005·Arthritis and Rheumatism·Désirée van der HeijdeUNKNOWN Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
Apr 24, 2007·Lancet·Jürgen Braun, Joachim Sieper
Sep 30, 2008·Arthritis and Rheumatism·Désirée van der HeijdeUNKNOWN Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
Aug 26, 2009·Arthritis Research & Therapy·Désirée van der HeijdeUNKNOWN ATLAS study group
Mar 17, 2010·The Journal of Rheumatology·Robert D InmanUNKNOWN CANDLE Study Group
Apr 5, 2011·The Journal of Rheumatology·Susanne J PedersenWalter P Maksymowych
Oct 20, 2011·Nature Reviews. Rheumatology·Rik Lories
May 21, 2013·Rheumatology International·Marina Amaral de Ávila MachadoFrancisco de Assis Acurcio
Apr 19, 2015·The Cochrane Database of Systematic Reviews·Lara J MaxwellGeorge A Wells
Nov 3, 2017·World Journal of Gastroenterology : WJG·Michele Maria LuchettiArmando Gabrielli
Nov 11, 2017·The Eurasian Journal of Medicine·Alper Uckun, Ilhan Sezer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.